Histological deep margins in cutaneous squamous cell carcinoma of the scalp and risk of recurrence

Authors: Júlia Verdaguer‐Faja, Álvaro Guerra‐Amor, Carla Ferrándiz‐Pulido, Carlos Abril‐Pérez, Rafael Botella Estrada, Emili Masferrer, Daniel Lopez‐Castillo, Gustavo Deza, Lorena Leal, Ignasi Marti‐Marti, Verónica Ruiz‐Salas, Mireia Yébenes, Laura Marqués Martin, Carola Baliu, Anna Castany, Aram Boada, Agustí Toll, Ane Jaka

Contributors: Universitat Autònoma de Barcelona. Departament de Medicina, [Verdaguer-Faja J, Boada A, Ferrándiz-Pulido C, Jaka A] Departament de Medicina, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain. [Guerra-Amor A] Servei de Dermatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Abril-Pérez C, Botella-Estrada R] Department of Dermatology, Hospital Universitario La Fe, Instituto de Investigación Sanitaria La Fe (ISS La Fe), Valencia, Spain. [Masferrer E, López-Castillo D] Department of Dermatology, Hospital Universitari Mútua Terrassa, Terrassa, Spain. [Deza G, Leal L] Department of Dermatology, Hospital del Mar, Institut Mar d'Investigacions Mèdiques, Barcelona, Spain. [Marti-Marti I, Toll A] Department of Dermatology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. [Ruiz-Salas V] Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [Yébenes M] Department of Dermatology, Hospital Parc Taulí, Sabadell, Spain. [Marques Martin L] Department of Dermatology, Hospital de Santa Caterina, Girona, Spain. [Baliu C, Castany A] Department of Dermatology, Hospital Universitari d'Igualada, Igualada, Spain, Institut d'Assistència Sanitària

Source: J Eur Acad Dermatol Venereol
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Instituto de Investigación Sanitaria La Fe (IIS La Fe)
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname

Subject Terms: Otros calificadores::Otros calificadores::Otros calificadores::/epidemiología, Male, Skin Neoplasms, IMPACT, DISEASES::Skin and Connective Tissue Diseases::Skin Diseases::Scalp Dermatoses, LOCAL RECURRENCE, Cuir cabellut - Malalties, Original Articles and Systematic Reviews, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Carcinoma::Carcinoma, Squamous Cell, EXCISION, 03 medical and health sciences, PROGNOSTIC-FACTORS, 0302 clinical medicine, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello, Risk Factors, Humans, HEAD, ENFERMEDADES::enfermedades de la piel y tejido conjuntivo::enfermedades de la piel::dermatosis del cuero cabelludo, NECK, Tumors, Retrospective Studies, Aged, Aged, 80 and over, SKIN-CANCER, Scalp, DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Neoplastic Processes::Neoplasm Recurrence, Local, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias glandulares y epiteliales::carcinoma::carcinoma de células escamosas, Margins of Excision, Middle Aged, Pell - Càncer, Head and Neck Neoplasms, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, METASTASIS, Carcinoma, Squamous Cell, Female, Other subheadings::Other subheadings::Other subheadings::/epidemiology, Neoplasm Recurrence, Local

File Description: application/pdf; pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39036869
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=15098
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=21137
http://hdl.handle.net/11351/12865

A probabilistic model of bilateral lymphatic spread in head and neck cancer

Authors: Ludwig, Roman, Pérez Haas, Yoel, Benavente, Sergi, Balermpas, Panagiotis, Unkelbach, Jan

Contributors: Institut Català de la Salut, [Ludwig R, Pérez Haas Y, Unkelbach J] Physics, University of Zurich, Zurich, Switzerland. Radiation Oncology, University Hospital Zurich, Zurich, Switzerland. [Benavente S] Servei d’Oncologia Radioteràpica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Balermpas P] Radiation Oncology, University Hospital Zurich, Zurich, Switzerland, Vall d'Hebron Barcelona Hospital Campus, University of Zurich, Ludwig, Roman

Source: Sci Rep
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Scientific Reports, Vol 15, Iss 1, Pp 1-21 (2025)

Subject Terms: 1000 Multidisciplinary, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::estadística como asunto::modelos estadísticos, Otros calificadores::Otros calificadores::Otros calificadores::/radioterapia, ENFERMEDADES::neoplasias::procesos neoplásicos::metástasis neoplásica::metástasis linfática, Science, Metàstasi limfàtica, FOS: Physical sciences, 610 Medicine & health, 10192 Physics Institute, Estadística, Coll - Càncer - Radioteràpia, 10044 Clinic for Radiation Oncology, Physics - Medical Physics, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Models, Statistical, Article, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms, Cap - Càncer - Radioteràpia, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Metastasis::Lymphatic Metastasis, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello, Medicine, Medical Physics (physics.med-ph), Other subheadings::Other subheadings::Other subheadings::/radiotherapy

File Description: application/pdf; Ludwig_40415030.pdf - application/pdf

Access URL: http://arxiv.org/abs/2501.16910
http://hdl.handle.net/11351/13405
https://doaj.org/article/f6cab7b2ce094db9bd5b26dd0d5d8d0a
https://www.zora.uzh.ch/id/eprint/278888/
https://doi.org/10.5167/uzh-278888

Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer

Authors: Even, Caroline, Massarelli, Erminia, Laban, Simon, FAYETTE, Jérôme, Oliva Bernal, Marc, Harrington, Kevin, Brana, Irene

Contributors: Institut Català de la Salut, Even C Head and Neck Oncology, Gustave Roussy Institute, Villejuif, Île-de-France, France. Harrington KJ Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK. Massarelli E Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, California, USA. Laban S Department of Otorhinolaryngology and Head and Neck Surgery, Universitatsklinikum Ulm, Ulm, Germany. Fayette J Centre Léon Bérard, Lyon, France. Oliva M Institut Català d’Oncologia, L’Hospitalet de Llobregat, Spain. Braña I Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

Source: Scientia

Subject Terms: Avaluació de resultats (Assistència sanitària), Quimioteràpia combinada, Anticossos monoclonals - Ús terapèutic, Cap - Càncer - Tractament, Coll - Càncer - Tractament, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, Humanized, AND EQUIPMENT::Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales::anticuerpos monoclonales humanizados, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia

File Description: application/pdf

Relation: Journal for ImmunoTherapy of Cancer;13(9); https://doi.org/10.1136/jitc-2025-012555; https://hdl.handle.net/11351/14051; 001569022500001

Availability: https://hdl.handle.net/11351/14051
https://doi.org/10.1136/jitc-2025-012555

Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study

Authors: Kevin J. Harrington, Barbara Burtness, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro, Amanda Psyrri, Irene Brana, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett G.M. Hughes, Ricard Mesia, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Jianxin Lin, Burak Gumuscu, Ramona F. Swaby, Danny Rischin

Contributors: Institut Català de la Salut, [Harrington KJ] The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, National Institute of Health Research Biomedical Research Centre, London, United Kingdom. [Burtness B] Yale Cancer Center and Yale School of Medicine, New Haven, CT. [Greil R] Salzburg Cancer Research Institute-Center for Clinical Cancer and Immunology Trials, Salzburg, Austria. Paracelsus Medical University Hospital, and Cancer Cluster Salzburg, Salzburg, Austria. [Soulières D] Centre Hospitalier de l’Université de Montréal, Montréal, QC, Canada. [Tahara M] National Cancer Center Hospital East, Kashiwa, Japan. [de Castro G Jr] Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, Brazil. [Brana I, Basté N] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Harrington, Kevin

Source: J Clin Oncol
JOURNAL OF CLINICAL ONCOLOGY
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Articles publicats en revistes (Ciències Clíniques)
Dipòsit Digital de la UB

Subject Terms: Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols, Cetuximab, R Medicine (General), Quimioteràpia combinada, B7-H1 Antigen, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms, Head cancer, 03 medical and health sciences, 0302 clinical medicine, Coll - Càncer - Tractament, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales, Quimioteràpia, Antineoplastic Combined Chemotherapy Protocols, Chemotherapy, Humans, Càncer de cap, Other subheadings::Other subheadings::Other subheadings::/drug therapy, Anticossos monoclonals - Ús terapèutic, RC0254 Neoplasms. Tumors. Oncology (including Cancer), Squamous Cell Carcinoma of Head and Neck, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal, ORIGINAL REPORTS, Neck cancer, Cap - Càncer - Tractament, Càncer de coll, 3. Good health, Head and Neck Neoplasms, Monoclonal antibodies, Neoplasm Recurrence, Local, Anticossos monoclonals

File Description: application/pdf; Print-Electronic

Access URL: https://pubmed.ncbi.nlm.nih.gov/36219809
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11671
https://hdl.handle.net/11351/9099
https://hdl.handle.net/2445/195805
https://pergamos.lib.uoa.gr/uoa/dl/object/3342772
http://hdl.handle.net/2445/195805

Remodeling the tumor microenvironment to overcome treatment resistance in HPV-negative head and neck cancer

Authors: Benavente, Sergi

Contributors: Institut Català de la Salut, Servei d’Oncologia Radioteràpica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

Source: Cancer Drug Resist
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname

Subject Terms: TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello, PHENOMENA AND PROCESSES::Cell Physiological Phenomena::Cellular Microenvironment::Tumor Microenvironment, Cap - Càncer - Immunoteràpia, Review, FENÓMENOS Y PROCESOS::fenómenos fisiológicos celulares::microambiente celular::microambiente tumoral, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy, Coll - Càncer - Immunoteràpia, 3. Good health, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/37457128
https://hdl.handle.net/11351/10095

Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology

Authors: José Trigo, Mónica García-Cosío, Almudena García-Castaño, Montserrat Gomà, Ricard Mesia-Nin, Elena Ruiz-Bravo, Ainara Soria-Rivas, Paola Castillo, Irene Braña-García, Margarita Alberola-Ferranti

Contributors: Institut Català de la Salut, [Trigo J] HC Marbella International Hospital, Spanish Society of Medical Oncology (SEOM), Marbella, Spain. [García-Cosío M] Ramón y Cajal University Hospital, Spanish Society of Pathological Anatomy (SEAP), Madrid, Spain. [García-Castaño A] Marqués de Valdecilla University Hospital, Spanish Society of Medical Oncology (SEOM), Santander, Spain. [Gomà M] Bellvitge University Hospital, Spanish Society of Pathological Anatomy (SEAP), Hospitalet de Llobregat, Spain. [Mesia-Nin R] Catalan Institute of Oncology (ICO), Badalona Applied Research Group in Oncology, Germans Trias i Pujol Research Institute, Spanish Society of Medical Oncology (SEOM), Badalona, Spain. [Ruiz-Bravo E] La Paz University Hospital, Spanish Society of Pathological Anatomy (SEAP), Madrid, Spain. [Braña-García I] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Spanish Society of Medical Oncology (SEOM), Barcelona, Spain. [Alberola-Ferranti M] Vall d’Hebron Hospital Universitari, Spanish Society of Pathological Anatomy (SEAP), Barcelona, Spain, Departament de Salut

Source: Clin Transl Oncol
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
CLINICAL & TRANSLATIONAL ONCOLOGY
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Institut de Recerca Germans Trias i Pujol (IGTP)

Subject Terms: PD-L1, Human papillomavirus, Epstein-Barr Virus Infections, Herpesvirus 4, Human, CHEMICALS AND DRUGS::Biological Factors::Biomarkers::Biomarkers, Tumor, Consensus, COMPUESTOS QUÍMICOS Y DROGAS::factores biológicos::biomarcadores::marcadores tumorales, Cap - Càncer, Medical Oncology, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms, Special Article, 03 medical and health sciences, Glàndules salivals - Càncer, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello::neoplasias de la boca::neoplasias de las glándulas salivales, 0302 clinical medicine, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello, Individualized therapy, Biomarkers, Tumor, Humans, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms::Mouth Neoplasms::Salivary Gland Neoplasms, Epstein Barr virus, Prognosis, Salivary Gland Neoplasms, 3. Good health, Head and Neck Neoplasms, Marcadors bioquímics, Response to treatment

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/36599600
https://pubmed.ncbi.nlm.nih.gov/35739348
https://hdl.handle.net/20.500.12530/88140
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2581
https://hdl.handle.net/11351/8153
https://hdl.handle.net/20.500.12530/114550

Confounding factors in the assessment of oral mucositis in head and neck cancer

Authors: Lorini, Luigi, Perri, Francesco, Vecchio, Stefania, Belgioia, Liliana, Vinches, Marie, Brana, Irene, Elad, Sharon, Bossi, Paolo

Contributors: Institut Català de la Salut, Radiological Sciences & Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy. [Perri F] Head and Neck Cancer Unit, Istituto Nazionale Tumori Di Napoli, IRCCS 'G. Pascale', Naples, Italy. [Vecchio S] Medical Oncology, IRCCS San Martino, IST National Cancer Institute and University of Genova, Genoa, Italy. [Belgioia L] Radiation Oncology Department, Health Science Department (DISSAL), IRCCS Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy. [Vinches M] Montpellier Cancer Research Institute, Montpellier, Languedoc-Roussillon, France. [Brana I] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Elad S] Oral Medicine, Eastman Institute for Oral Health, University of Rochester Medical Center, Rochester, NY, USA, Vall d'Hebron Barcelona Hospital Campus

Source: Support Care Cancer
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname

Subject Terms: Mucositis, Stomatitis, ENFERMEDADES::enfermedades del sistema digestivo::enfermedades gastrointestinales::gastroenteritis::mucositis, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::radioterapia, Mucosa oral - Malalties, Review Article, Coll - Càncer - Radioteràpia, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Radiotherapy, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms, Otros calificadores::Otros calificadores::Otros calificadores::/efectos adversos, 3. Good health, Cap - Càncer - Radioteràpia, 03 medical and health sciences, 0302 clinical medicine, Other subheadings::Other subheadings::Other subheadings::/adverse effects, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello, Head and neck, Radiation toxicities, Simultaneous care, Supportive care, Head and Neck Neoplasms, DISEASES::Digestive System Diseases::Gastrointestinal Diseases::Gastroenteritis::Mucositis, Quality of Life, Humans

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/35639187
https://hdl.handle.net/11351/8409

A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysis

Authors: Jiménez-Labaig, Pablo, Aymerich, Clàudia, Rullán, Antonio José, Cacicedo, Jon, Gonzalez-Torres, Miguel Angel, Brana, Irene

Contributors: Institut Català de la Salut, Jimenez-Labaig P, Rullan A Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK. The Institute of Cancer Research, National Institute of Health Research Biomedical Research Centre, London, UK. Aymerich C Psychiatry Department, Basurto University Hospital. Osakidetza, Basque Health Service, Bilbao, Spain. Biobizkaia Health Research Institute, OSI Bilbao-Basurto, Bilbao, Spain. Centro de Investigación en Red de Salud Mental (CIBERSAM), Madrid, Spain. Braña I Grup de Tumors Toràcics i Càncer de Cap i Coll, Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Cacicedo J Radiotherapy Department, Cruces University Hospital, Barakaldo, Spain. Biobizkaia Health Research Institute, OSI Ezkerraldea Enkarterri Cruces, Barakaldo, Spain. Faculty of Medicine, University of the Basque Country, Leioa, Spain. González-Torres MÁ Psychiatry Department, Basurto University Hospital. Osakidetza, Basque Health Service, Bilbao, Spain. Biobizkaia Health Research Institute, OSI Bilbao-Basurto, Bilbao, Spain. Centro de Investigación en Red de Salud Mental (CIBERSAM), Madrid, Spain. Neuroscience Department, University of the Basque Country (UPV/EHU), Leioa, Spain, Vall d'Hebron Barcelona Hospital Campus

Source: Scientia

Subject Terms: Suïcidi, Salut mental, Cap - Càncer, Coll - Càncer, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms, PSYCHIATRY AND PSYCHOLOGY::Behavior and Behavior Mechanisms::Behavior::Behavioral Symptoms::Self-Injurious Behavior::Suicide, PSYCHIATRY AND PSYCHOLOGY::Psychological Phenomena::Mental Health, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity::Prevalence, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello, PSIQUIATRÍA Y PSICOLOGÍA::conducta y mecanismos de la conducta::conducta::síntomas conductuales::conducta autolesiva::suicidio, PSIQUIATRÍA Y PSICOLOGÍA::fenómenos psicológicos::salud mental, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::recopilación de datos::estadísticas vitales::morbilidad::prevalencia

File Description: application/pdf

Relation: JNCI Cancer Spectrum;8(3); https://doi.org/10.1093/jncics/pkae031; https://hdl.handle.net/11351/11580; 001238015400001

Availability: https://hdl.handle.net/11351/11580
https://doi.org/10.1093/jncics/pkae031

Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement: an ASTRO-ESTRO consensus statement

Authors: Thomson D. J., Palma D., Guckenberger M., Balermpas P., Beitler J. J., Blanchard P., Brizel D., Budach W., Caudell J., Corry J., Corvo R., Evans M., Garden A. S., Giralt J., Gregoire V., Harari P. M., Harrington K., Hitchcock Y. J., Johansen J., Kaanders J., Koyfman S., Langendijk J. A., Le Q. -T., Lee N., Margalit D., Mierzwa M., Porceddu S., Soong Y. L., Sun Y., Thariat J., Waldron J., Yom S. S.

Contributors: Institut Català de la Salut, [Thomson DJ] Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, and the Division of Cancer Sciences, The University of Manchester, UK. [Palma D] Division of Radiation Oncology, Western University, London, Canada. [Guckenberger M, Balermpas P] Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. [Beitler JJ] Department of Radiation Oncology, Emory University, Atlanta, Georgia. [Blanchard P] Department of Radiation Oncology, Gustave Roussy Cancer Center, Villejuif, France. [Giralt J] Servei d’Oncologia Radioteràpica, Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

Source: Radiother Oncol
Int J Radiat Oncol Biol Phys
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
International Journal of Radiation Oncology, Biology, Physics, 107, 4, pp. 618-627
Radiotherapy and Oncology, 151, pp. 314-321
Thomson, D J, Palma, D, Guckenberger, M, Balermpas, P, Beitler, J J, Blanchard, P, Brizel, D, Budach, W, Caudell, J, Corry, J, Corvo, R, Evans, M, Garden, A S, Giralt, J, Gregoire, V, Harari, P M, Harrington, K, Hitchcock, Y J, Johansen, J, Kaanders, J, Koyfman, S, Langendijk, J A, Le, Q T, Lee, N, Margalit, D, Mierzwa, M, Porceddu, S, Soong, Y L, Sun, Y, Thariat, J, Waldron, J & Yom, S S 2020, ' Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic : An ASTRO-ESTRO Consensus Statement ', International Journal of Radiation Oncology Biology Physics, vol. 107, no. 4, pp. 618-627 . https://doi.org/10.1016/j.ijrobp.2020.04.016
Thomson, D J, Palma, D, Guckenberger, M, Balermpas, P, Beitler, J J, Blanchard, P, Brizel, D, Budach, W, Caudell, J, Corry, J, Corvo, R, Evans, M, Garden, A S, Giralt, J, Gregoire, V, Harari, P M, Harrington, K, Hitchcock, Y J, Johansen, J, Kaanders, J, Koyfman, S, Langendijk, J A, Le, Q T, Lee, N, Margalit, D, Mierzwa, M, Porceddu, S, Soong, Y L, Sun, Y, Thariat, J, Waldron, J & Yom, S S 2020, ' Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic : An ASTRO-ESTRO consensus statement ', Radiotherapy and Oncology, vol. 151, pp. 314-321 . https://doi.org/10.1016/j.radonc.2020.04.019
International Journal of Radiation Oncology • Biology • Physics, vol 107, iss 4
Radiotherapy and Oncology

Subject Terms: Cancer Research, Otros calificadores::Otros calificadores::Otros calificadores::/radioterapia, 2720 Hematology, Clinical sciences, Coll - Càncer - Radioteràpia, Medical Oncology, COVID-19 (Malaltia), 0302 clinical medicine, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello, DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, Pandèmia de COVID-19, 2020, 1306 Cancer Research, Viral, Other subheadings::Other subheadings::Other subheadings::/radiotherapy, Societies, Medical, Cancer, Radiation, Hematology, 3. Good health, Other Physical Sciences, Cap - Càncer - Radioteràpia, Oncology, Radiology Nuclear Medicine and imaging, Head and Neck Neoplasms, Physical Sciences, Radiation Oncology - Radboud University Medical Center, Practice Guidelines as Topic, 2741 Radiology Nuclear Medicine and imaging, 2730 Oncology, SQUAMOUS-CELL CARCINOMA, Coronavirus Infections, HEALTH CARE::Environment and Public Health::Public Health::Disease Outbreaks::Epidemics::Pandemics, COVID-19 Rapid Communication, Consensus, Clinical Sciences, Oncology and Carcinogenesis, Pneumonia, Viral, Article, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms, 03 medical and health sciences, Clinical Research, Medical, Humans, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus, Oncology & Carcinogenesis, Dental/Oral and Craniofacial Disease, Pandemics, Medical and biological physics, Biomedical and Clinical Sciences, Prevention, COVID-19, Oncology and carcinogenesis, Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences, Pneumonia, Medical and Biological Physics, 3108 Radiation, Good Health and Well Being, ATENCIÓN DE SALUD::ambiente y salud pública::salud pública::brotes de enfermedades::epidemias::pandemias, Societies

File Description: application/pdf

Access URL: http://www.thegreenjournal.com/article/S0167814020302000/pdf
http://www.redjournal.org/article/S0360301620310348/pdf
https://pubmed.ncbi.nlm.nih.gov/32730830
https://pubmed.ncbi.nlm.nih.gov/32302681
https://hdl.handle.net/11351/6480
https://hdl.handle.net/11351/6444
https://research.rug.nl/en/publications/b4b9461b-1cbf-4e9e-a824-9b74044142db
https://hdl.handle.net/11370/b4b9461b-1cbf-4e9e-a824-9b74044142db
https://doi.org/10.1016/j.radonc.2020.04.019
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194855
https://escholarship.org/content/qt5f08z0k8/qt5f08z0k8.pdf?t=qf72x4
https://europepmc.org/article/MED/32302681
https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/covidwho-275257
https://repository.ubn.ru.nl/handle/2066/229919
https://christie.openrepository.com/handle/10541/623277
https://hdl.handle.net/2066/220461
https://repository.ubn.ru.nl//bitstream/handle/2066/220461/220461.pdf
https://repository.ubn.ru.nl//bitstream/handle/2066/229919/229919.pdf
https://hdl.handle.net/2066/229919
https://findresearcher.sdu.dk:8443/ws/files/170764758/PIIS0360301620310348.pdf
https://findresearcher.sdu.dk:8443/ws/files/173724727/PIIS0167814020302000.pdf
https://hdl.handle.net/11567/1020220
https://doi.org/10.1016/j.radonc.2020.04.019
https://escholarship.org/uc/item/5f08z0k8
https://escholarship.org/uc/item/6sp3k3cm
https://escholarship.org/content/qt6sp3k3cm/qt6sp3k3cm.pdf

Outcomes Following Autologous Fat Grafting in Patients with Sequelae of Head and Neck Cancer Treatment

Authors: Masiá Gridilla, Jordi, Gutierrez Santamaria, Javier, Alvarez-Saez, Iago, Pamias Romero, Jorge, Saez barba, Manuel, Bescós Atin, Coro

Contributors: Institut Català de la Salut, Masià-Gridilla J, Álvarez-Sáez I, Pamias-Romero J, Saez-Barba M Grup de Recerca en Noves Tecnologies i Microcirurgia Craniofacial, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servei de Cirurgia Oral i Maxil·lofacial, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Gutiérrez-Santamaría J Grup de Recerca en Noves Tecnologies i Microcirurgia Craniofacial, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Bescós-Atin C Grup de Recerca en Noves Tecnologies i Microcirurgia Craniofacial, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servei de Cirurgia Oral i Maxil·lofacial, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

Source: Scientia

Subject Terms: Cap - Càncer - Cirurgia, Coll - Càncer - Cirurgia, Cirurgia plàstica, Trasplantació d'òrgans, teixits, etc, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Surgical Procedures, Operative::Transplantation::Transplantation, Autologous, ANATOMY::Tissues::Connective Tissue::Adipose Tissue::Adipose Tissue, White::Subcutaneous Fat, Other subheadings::Other subheadings::Other subheadings::Other subheadings::/transplantation, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms, Other subheadings::Other subheadings::Other subheadings::/surgery, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::intervenciones quirúrgicas::trasplante::trasplante autólogo, ANATOMÍA::tejidos::tejido conectivo::tejido adiposo::tejido adiposo blanco::grasa subcutánea, Otros calificadores::Otros calificadores::Otros calificadores::Otros calificadores::/trasplante, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello, Otros calificadores::Otros calificadores::Otros calificadores::/cirugía

File Description: application/pdf

Relation: Cancers;15(3); https://doi.org/10.3390/cancers15030800; https://hdl.handle.net/11351/9179; 000929338900001

Availability: https://hdl.handle.net/11351/9179
https://doi.org/10.3390/cancers15030800

Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy

Authors: Zandberg, Dan P., Algazi, Alain P., Jimeno, Antonio, Good, James S., Fayette, Jerome, Bouganim, Nathaniel, Ready, Neal E., Clement, Paul M., Even, Caroline, Jang, Raymond W., Wong, Stuart, Keilholz, Ulrich, Gilbert, Jill, Fenton, Moon, Brana, Irene, Henry, Stephanie, Remenar, Eva, Papai, Zsuzsanna, Siu, Lillian L., Jarkowski, Anthony, Armstrong, Jon M., Asubonteng, Kobby, Fan, Jean, Melillo, Giovanni, Mesia, Ricard

Contributors: Institut Català de la Salut, [Zandberg DP] University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA, USA. [Algazi AP] University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. [Jimeno A] Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA. [Good JS] Institute of Head and Neck Studies and Education, Queen Elizabeth Hospital, Birmingham, UK. [Fayette J] Clinical Oncology, Cancer Center Centre Léon Bérard, University of Lyon, Lyon, France. [Bouganim N] Department of Oncology, McGill University Health Centre, Montreal, QC, Canada. [Braña I] Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, UCL - (MGD) Service d'oncologie médicale, UCL - SSS/IREC/MONT - Pôle Mont Godinne

Source: Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Dipòsit Digital de la UB
Universidad de Barcelona
Scientia
Recercat. Dipósit de la Recerca de Catalunya
instname
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
European journal of cancer, Vol. 107, p. 142-152 (2019)

Subject Terms: Male, Survival rate, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, MULTICENTER, Cap - Càncer, neoplasias::neoplasias por tipo histológico::neoplasias glandulares y epiteliales::carcinoma::carcinoma de células escamosas::carcinoma de células escamosas de cabeza y cuello [ENFERMEDADES], Other subheadings::Other subheadings::/drug therapy [Other subheadings], B7-H1 Antigen, Antineoplastic Agents, Immunological, 0302 clinical medicine, DISEASES::Neoplasms::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms::Squamous Cell Carcinoma of Head and Neck, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello, Neoplasms::Neoplasms by Site::Head and Neck Neoplasms [DISEASES], Monoclonal, Quimioteràpia, Head and neck cancer, Càncer de cap, aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales [COMPUESTOS QUÍMICOS Y DROGAS], AGENT, Aged, 80 and over, Other subheadings::Other subheadings::Other subheadings::/drug therapy, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal, Antibodies, Monoclonal, Middle Aged, OPEN-LABEL, Prognosis, CANCER, CETUXIMAB, METHOTREXATE, 3. Good health, Survival Rate, Oncology, Head and Neck Neoplasms, SAFETY, Lymphatic Metastasis, Female, Immunotherapy, Life Sciences & Biomedicine, Adult, HPV, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Antibodies, GEFITINIB, 1117 Public Health and Health Services, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms, Coll - Càncer, Head cancer, Young Adult, 03 medical and health sciences, 3211 Oncology and carcinogenesis, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales, Biomarkers, Tumor, neoplasias::neoplasias por localización::neoplasias de cabeza y cuello [ENFERMEDADES], Chemotherapy, Humans, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, PEMBROLIZUMAB, Aged, Salvage Therapy, Science & Technology, Recurrent or metastatic, Squamous Cell Carcinoma of Head and Neck, International Agencies, EFFICACY, Neck cancer, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias glandulares y epiteliales::carcinoma::carcinoma de células escamosas::carcinoma de células escamosas de cabeza y cuello, Càncer de coll, Neoplasms::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms::Squamous Cell Carcinoma of Head and Neck [DISEASES], Neoplasm Recurrence, Local, Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal [CHEMICALS AND DRUGS], Anticossos monoclonals, Follow-Up Studies

File Description: application/pdf

Access URL: http://www.ejcancer.com/article/S0959804918315132/pdf
https://pubmed.ncbi.nlm.nih.gov/30576970
https://hdl.handle.net/2445/171696
http://hdl.handle.net/2445/171696
http://hdl.handle.net/11351/5761
https://hdl.handle.net/11351/5761
https://www.ncbi.nlm.nih.gov/pubmed/30576970
http://diposit.ub.edu/dspace/bitstream/2445/171696/3/ZandbergDP.pdf
http://diposit.ub.edu/dspace/handle/2445/171696
https://pubmed.ncbi.nlm.nih.gov/30576970/
https://www.sciencedirect.com/science/article/pii/S0959804918315132
https://europepmc.org/article/MED/30576970
https://lirias.kuleuven.be/handle/123456789/647095
https://doi.org/10.1016/j.ejca.2018.11.015
https://hdl.handle.net/2078.1/210170

Defining a Standard Set of Health Outcomes for Patients With Squamous Cell Carcinoma of the Head and Neck in Spain

Authors: Cajaraville-Ordoñana, Gerardo, Cantero, David, Mesia, Ricard, Giralt López de Sagredo, Jordi, Monje, Florencio, Arrazubi, Virginia

Contributors: Institut Català de la Salut, Arrazubi V Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain. Cajaraville G Hospital Pharmacy, Fundación Onkologikoa, San Sebastián, Spain. Cantero D Quality and Innovation, Organización Sanitaria Integrada (Integrated Health Organisation) (OSI) Barrualde Galdakao, Galdakao, Spain. Giralt J Servei d’Oncologia Radioteràpica, Vall d´Hebron Hospital Universitari, Barcelona, Spain. Mesia R Medical Oncology, Institut Català d’Oncología, Group Badalona Applied Research Group in Oncology (B-ARGO) Group, Institut d'Investigació Germans Trias i Pujol (IGTP), Badalona, Spain. Monje F Oral and Maxillofacial Surgery, Hospital Universitario de Badajoz, Badajoz, Spain, Vall d'Hebron Barcelona Hospital Campus

Source: Scientia

Subject Terms: Pacients - Satisfacció, Cap - Càncer, Coll - Càncer, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello

File Description: application/pdf

Relation: Frontiers in Oncology;11; https://doi.org/10.3389/fonc.2021.747520; Arrazubi V, Cajaraville G, Cantero D, Giralt J, Mesia R, Monje F, et al. Defining a Standard Set of Health Outcomes for Patients With Squamous Cell Carcinoma of the Head and Neck in Spain. Front Oncol. 2022 Jan 24;11:747520.; https://hdl.handle.net/11351/7839; 000751848200001

Availability: https://hdl.handle.net/11351/7839
https://doi.org/10.3389/fonc.2021.747520

SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation

Authors: Mir Perez, Cristina, Garcia Mayea, Yoelsis, García Murias, Laia, Herrero, Pol, Canela, Nuria, Tabernero, Rocio, Lorente Guerrero, Juan, Castellví Vives, Josep, Lleonart Pajarin, Matilde

Contributors: Institut Català de la Salut, Mir C Grup de Recerca Biomèdica en Cèl•lules Mare del Càncer, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Faculty of Medicine, University of Barcelona, Barcelona, Spain. Garcia-Mayea Y, Garcia L, Castellvi J Grup de Recerca Biomèdica en Cèl•lules Mare del Càncer, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Herrero P, Canela N Eurecat, Centre Tecnològic de Catalunya–Centre for Omic Sciences (COS), Joint Unit Universitat Rovira i Virgili-EURECAT, Reus, Spain. Tabernero R, Lorente J Servei d’Otorinolaringologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. LLeonart ME Grup de Recerca Biomèdica en Cèl•lules Mare del Càncer, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Spanish Biomedical Research Network Centre in Oncology, CIBERONC, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

Source: Scientia

Subject Terms: Coll - Càncer - Tractament, Cap - Càncer - Tractament, Resistència als medicaments, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Carcinoma::Carcinoma, Squamous Cell, PHENOMENA AND PROCESSES::Physiological Phenomena::Pharmacological and Toxicological Phenomena::Pharmacological Phenomena::Drug Resistance::Drug Resistance, Neoplasm, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias glandulares y epiteliales::carcinoma::carcinoma de células escamosas, FENÓMENOS Y PROCESOS::fenómenos fisiológicos::fenómenos farmacológicos y toxicológicos::fenómenos farmacológicos::resistencia a medicamentos::resistencia a los antineoplásicos

File Description: application/pdf

Relation: Cancers;13(19); https://doi.org/10.3390/cancers13194952; info:eu-repo/grantAgreement/ES/PE2013-2016/PI15%2F01262; https://hdl.handle.net/11351/7478; 000773923000043

Availability: https://hdl.handle.net/11351/7478
https://doi.org/10.3390/cancers13194952

Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement

Authors: Thomson, David J., Palma, David, Guckenberger, Matthias, Beitler, Jonathan J., Giralt López de Sagredo, Jordi, Blanchard, Pierre, Balermpas, Panagiotis

Contributors: Institut Català de la Salut, Thomson DJ Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, and the Division of Cancer Sciences, The University of Manchester, UK. Palma D Division of Radiation Oncology, Western University, London, Canada. Guckenberger M, Balermpas P Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Beitler JJ Department of Radiation Oncology, Emory University, Atlanta, Georgia. Blanchard P Department of Radiation Oncology, Gustave Roussy Cancer Center, Villejuif, France. Giralt J Servei d’Oncologia Radioteràpica, Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

Source: Scientia

Subject Terms: Pandèmia de COVID-19, 2020-, Cap - Càncer - Radioteràpia, Coll - Càncer - Radioteràpia, HEALTH CARE::Environment and Public Health::Public Health::Disease Outbreaks::Epidemics::Pandemics, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms, Other subheadings::Other subheadings::Other subheadings::/radiotherapy, DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, ATENCIÓN DE SALUD::ambiente y salud pública::salud pública::brotes de enfermedades::epidemias::pandemias, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello, Otros calificadores::Otros calificadores::Otros calificadores::/radioterapia, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus

File Description: application/pdf

Relation: International Journal of Radiation Oncology, Biology, Physics;107(4); https://doi.org/10.1016/j.ijrobp.2020.04.016; https://hdl.handle.net/11351/6444; 000544182500004

Availability: https://hdl.handle.net/11351/6444
https://doi.org/10.1016/j.ijrobp.2020.04.016

ICO-ICS Praxi per al tractament mèdic i amb irradiació del càncer d'orofaringe, hipofaringe, laringe i nasofaringe

Authors: Basté Rotllan, Neus, Benavente Norza, Sergio, Braña Garcia, Irene, Cirauqui-Cirauqui, Beatriz, Felip Font, Enriqueta, Lozano-Borbalas, Alicia, Marruecos-Querol, Jordi, Mesia, Ricard, Miguelsanz-García, Santiago, Taberna Sanz, Miren, Vázquez-Fernández, Silvia, Rubió-Casadevall, Jordi

Contributors: [Basté Rotllan N, Braña-García I] Servei d’Oncologia Mèdica, Hospital Universitari Vall d’Hebron, Institut Català de la Salut (ICS), Generalitat de Catalunya, Barcelona, Spain. Vall d’Hebron Institut d’Oncologia (VHIO), Generalitat de Catalunya, Barcelona, Spain. [Benavente-Norza S] Servei d’Oncologia Radioteràpica, Hospital Universitari Vall d’Hebron, Institut Català de la Salut (ICS), Generalitat de Catalunya, Barcelona, Spain. Vall d’Hebron Institut d’Oncologia (VHIO), Generalitat de Catalunya, Barcelona, Spain. [Cirauqui-Cirauqui B] Servei d’Oncologia Mèdica, Institut Català d’Oncologia (ICO) Badalona, Generalitat de Catalunya, Badalona, Spain. [Felip-Font E] ] Servei d’Oncologia Mèdica, Hospital Universitari Vall d’Hebron, Institut Català de la Salut (ICS), Generalitat de Catalunya, Barcelona, Spain. Vall d’Hebron Institut d’Oncologia (VHIO), Generalitat de Catalunya, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Lozano-Borbalas A] Servei d’Oncologia Radioteràpica, Institut Català d’Oncologia (ICO) L’Hospitalet, Generalitat de Catalunya, L’Hospitalet de Llobregat, Spain. [Marruecos-Querol J] Servei d’Oncologia Radioteràpica, Institut Català d’Oncologia (ICO) Girona, Generalitat de Catalunya, Girona, Spain. [Mesía-Nin R, Taberna-Sanz M, Vázquez-Fernández S] Servei d’Oncologia Mèdica, Institut Català d’Oncologia (ICO) L’Hospitalet, Generalitat de Catalunya, L’Hospitalet de Llobregat, Spain. [Miguelsanz-García S] Servei d’Oncologia Mèdica, Hospital Universitari Arnau de Vilanova, Institut Català de la Salut (ICS), Generalitat de Catalunya, Lleida, Spain. [Rubió-Casadevall J] Servei d’Oncologia Mèdica, Institut Català d’Oncologia (ICO) Girona, Generalitat de Catalunya, Girona, Spain. Universitat de Girona, Girona, Spain. Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Generalitat de Catalunya, Girona, Spain., Institut Català de la Salut

Source: Scientia

Subject Terms: Otros calificadores::Otros calificadores::/terapia, Coll - Càncer - Tractament, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello, Càncer - Irradiació, Other subheadings::Other subheadings::/therapy, PHENOMENA AND PROCESSES::Physical Phenomena::Radiation, Cap - Càncer - Tractament, FENÓMENOS Y PROCESOS::fenómenos físicos::radiación, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms

File Description: application/pdf

Access URL: https://hdl.handle.net/11351/4568

Nivolumab per al tractament del càncer de cèl·lules escatoses de cap i coll en progressió durant o després d'un tractament basat en platí

Authors: Programa d'Harmonització Farmacoterapèutica

Contributors: Departament de Salut

Source: Scientia

Subject Terms: Other subheadings::Other subheadings::Other subheadings::/drug therapy, Otros calificadores::Otros calificadores::Otros calificadores::/tratamiento farmacológico, Other subheadings::Other subheadings::/therapeutic use, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, Humanized::Nivolumab, Otros calificadores::Otros calificadores::/uso terapéutico, Cap - Càncer - Tractament, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms, Platí - Ús terapèutic - Assaigs clínics, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::desarrollo de medicamentos::evaluación de medicamentos, Coll - Càncer - Tractament, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello, Medicaments - Assaigs clínics, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Drug Development::Drug Evaluation, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales::anticuerpos monoclonales humanizados::nivolumab

File Description: application/pdf

Access URL: https://hdl.handle.net/11351/4284

Nivolumab per al tractament del càncer de cèl·lules escatoses de cap i coll en progressió durant o després d'un tractament basat en platí

Authors: Programa d'Harmonització Farmacoterapèutica

Contributors: Departament de Salut

Source: Scientia

Subject Terms: Coll - Càncer - Tractament, Cap - Càncer - Tractament, Platí - Ús terapèutic - Assaigs clínics, Medicaments - Assaigs clínics, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, Humanized::Nivolumab, Other subheadings::Other subheadings::/therapeutic use, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Drug Development::Drug Evaluation, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello, Otros calificadores::Otros calificadores::Otros calificadores::/tratamiento farmacológico, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales::anticuerpos monoclonales humanizados::nivolumab, Otros calificadores::Otros calificadores::/uso terapéutico, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::desarrollo de medicamentos::evaluación de medicamentos

File Description: application/pdf

Relation: Programa d'harmonització farmacoterapèutica, Servei Català de la Salut; Programa d'harmonització farmacoterapèutica. Nivolumab per al tractament del càncer de cèl·lules escatoses de cap i coll en progressió durant o després d'un tractament basat en platí. Barcelona: Servei Català de la Salut; 2018.; https://hdl.handle.net/11351/4284

Availability: https://hdl.handle.net/11351/4284

ICO-ICS Praxi per al tractament mèdic i amb irradiació del càncer d'orofaringe, hipofaringe, laringe i nasofaringe ; ICO-ICS Praxis para el tratamiento médico y con irradiación del cáncer de orofaringe, hipofaringe, laringe y nasofaringe

Authors: Basté Rotllan, Neus, Benavente Norza, Sergio, Braña Garcia, Irene, Cirauqui-Cirauqui, Beatriz, Lozano-Borbalas, Alicia, Marruecos-Querol, Jordi, Mesia, Ricard, Miguelsanz-García, Santiago, Taberna Sanz, Miren, Vázquez-Fernández, Silvia, Rubió-Casadevall, Jordi, Felip Font, Enriqueta

Contributors: Basté Rotllan N, Braña-García I Servei d’Oncologia Mèdica, Hospital Universitari Vall d’Hebron, Institut Català de la Salut (ICS), Generalitat de Catalunya, Barcelona, Spain. Vall d’Hebron Institut d’Oncologia (VHIO), Generalitat de Catalunya, Barcelona, Spain. Benavente-Norza S Servei d’Oncologia Radioteràpica, Hospital Universitari Vall d’Hebron, Institut Català de la Salut (ICS), Generalitat de Catalunya, Barcelona, Spain. Vall d’Hebron Institut d’Oncologia (VHIO), Generalitat de Catalunya, Barcelona, Spain. Cirauqui-Cirauqui B Servei d’Oncologia Mèdica, Institut Català d’Oncologia (ICO) Badalona, Generalitat de Catalunya, Badalona, Spain. Felip-Font E Servei d’Oncologia Mèdica, Hospital Universitari Vall d’Hebron, Institut Català de la Salut (ICS), Generalitat de Catalunya, Barcelona, Spain. Vall d’Hebron Institut d’Oncologia (VHIO), Generalitat de Catalunya, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Lozano-Borbalas A Servei d’Oncologia Radioteràpica, Institut Català d’Oncologia (ICO) L’Hospitalet, Generalitat de Catalunya, L’Hospitalet de Llobregat, Spain. Marruecos-Querol J Servei d’Oncologia Radioteràpica, Institut Català d’Oncologia (ICO) Girona, Generalitat de Catalunya, Girona, Spain. Mesía-Nin R, Taberna-Sanz M, Vázquez-Fernández S Servei d’Oncologia Mèdica, Institut Català d’Oncologia (ICO) L’Hospitalet, Generalitat de Catalunya, L’Hospitalet de Llobregat, Spain. Miguelsanz-García S Servei d’Oncologia Mèdica, Hospital Universitari Arnau de Vilanova, Institut Català de la Salut (ICS), Generalitat de Catalunya, Lleida, Spain. Rubió-Casadevall J Servei d’Oncologia Mèdica, Institut Català d’Oncologia (ICO) Girona, Generalitat de Catalunya, Girona, Spain. Universitat de Girona, Girona, Spain. Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Generalitat de Catalunya, Girona, Spain., Institut Català de la Salut

Source: Scientia

Subject Terms: Cap - Càncer - Tractament, Coll - Càncer - Tractament, Càncer - Irradiació, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms, Other subheadings::Other subheadings::/therapy, PHENOMENA AND PROCESSES::Physical Phenomena::Radiation, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello, FENÓMENOS Y PROCESOS::fenómenos físicos::radiación, Otros calificadores::Otros calificadores::/terapia

File Description: application/pdf

Relation: ICO-ICSPraxi; 2a ed.; https://hdl.handle.net/11351/4568

Availability: https://hdl.handle.net/11351/4568